Early results of a multicenter phase 2 study: Weekly docetaxel and intermittent estramustin as combination chemotherapy in patients with hormone-refractory prostate cancer (HRPC)

✍ Scribed by U. Steiner; K. Miller; S. Machtens; B. Backhaus; M. Siegsmund

• Book ID: 118644251
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 226 KB
• Volume: 2
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/s1569-9056(03)80098-2